All-terrain vehicle injuries: are they dangerous? A 6-year experience at a level I trauma center after legislative regulations expired von Fonseca, A H, Ochsner, M G, Bromberg, W J, Gantt, D

Volltext

All-terrain vehicle injuries : Are they dangerous? A 6-year experience at a level I trauma center after legislative regulations expired. Discussion von FONSECA, A. H, OCHSNER, M. G, BARD, Michael R, GRYNWALD, Kirk, MARR, Alan B, FONSECA, Alvaro H, BROMBERG, W. J, GANTT, D, MICHAEL, M. S, ROTONDO, F, POOLE, Galen V, HAWKINS, Michael L, FIELD, Richard J, THRELKEL, James B

Volltext

Joseph Larner's personal odyssey: Search for the cause and cure of non-insulin-dependent diabetes mellitus von Bromberg, William J., Edlich, Richard F.

Volltext

Not So Fast von Miller, M. Todd, Pasquale, Michael D., Bromberg, William J., Wasser, Thomas E., Cox, John

Volltext

New advances in electronic devices for hole detection von Cox, Mary Jude, Bromberg, William J., Zura, Robert D., Foresman, Pamela A., Morgan, Raymond G., Edlich, Richard F.

Volltext

Adaptive clothing for persons with mobility disorders after burn injury von Eggleston, J M, Bentrem, D J, Bromberg, W J, London, S D, Biesecker, J E, Edlich, R F

Volltext

Adaptative clothing for persons with mobility disorders after burn injury von EGGLESTON, J. M, BENTREM, D. J, BROMBERG, W. J, LONDON, S. D, BIESECKER, J. E, EDLICH, R. F

Volltext

Recurrent subdural haematoma as the primary and sole manifestation of chronic lymphocytic leukaemia von E. C. BROMBERG, J., VANDERTOP, W. P., JANSEN, G. H.

Volltext

Human Microbiota Characterization in the Course of Renal Transplantation von Fricke, W. F., Maddox, C., Song, Y., Bromberg, J. S.

Volltext

CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies von BROMBERG, J. E. C, BREEMS, D. A, KRAAN, J, BIKKER, G, VAN DER HOLT, B, SMITT, P. Sillevis, VAN DEN BENT, M. J, VAN'T VEER, M, GRATAMA, J. W

Volltext

Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 tria... von Taal, Walter, MD, Oosterkamp, Hendrika M, MD, Walenkamp, Annemiek M E, MD, Dubbink, Hendrikus J, PhD, Beerepoot, Laurens V, MD, Hanse, Monique C J, MD, Buter, Jan, MD, Honkoop, Aafke H, MD, Boerman, Dolf, MD, de Vos, Filip Y F, MD, Dinjens, Winand N M, PhD, Enting, Roelien H, MD, Taphoorn, Martin J B, MD, van den Berkmortel, Franchette W P J, MD, Jansen, Rob L H, MD, Brandsma, Dieta, MD, Bromberg, Jacoline E C, MD, van Heuvel, Irene, Vernhout, René M, MSc, van der Holt, Bronno, PhD, van den Bent, Martin J, Prof

Volltext

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma von Hegi, Monika E, Diserens, Annie-Claire, Gorlia, Thierry, Hamou, Marie-France, de Tribolet, Nicolas, Weller, Michael, Kros, Johan M, Hainfellner, Johannes A, Mason, Warren, Mariani, Luigi, Bromberg, Jacoline E.C, Hau, Peter, Mirimanoff, René O, Cairncross, J. Gregory, Janzer, Robert C, Stupp, Roger

Volltext

Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel von Mevorach, Dror, Anis, Emilia, Cedar, Noa, Bromberg, Michal, Haas, Eric J, Nadir, Eyal, Olsha-Castell, Sharon, Arad, Dana, Hasin, Tal, Levi, Nir, Asleh, Rabea, Amir, Offer, Meir, Karen, Cohen, Dotan, Dichtiar, Rita, Novick, Deborah, Hershkovitz, Yael, Dagan, Ron, Leitersdorf, Iris, Ben-Ami, Ronen, Miskin, Ian, Saliba, Walid, Muhsen, Khitam, Levi, Yehezkel, Green, Manfred S, Keinan-Boker, Lital, Alroy-Preis, Sharon

Volltext

Improved Limits on Millicharged Particles Using the ArgoNeuT Experiment at Fermilab von Acciarri, R, Adams, C, Asaadi, J, Baller, B, Bolton, T, Bromberg, C, Cavanna, F, Edmunds, D, Fitzpatrick, R S, Fleming, B, Harnik, R, James, C, Lepetic, I, Littlejohn, B R, Liu, Z, Luo, X, Palamara, O, Scanavini, G, Soderberg, M, Spitz, J, Szelc, A M, Wu, W, Yang, T

Volltext

IDH1 mutations in low-grade astrocytomas predict survival but not response to temozolomide von DUBBINK, H. J, TAAL, W, BOOGERD, W, GROENENDIJK, F. H, SILLEVIS SMITT, PA. E, DINJENS, W. N. M, VAN DEN BENT, M. J, VAN MARION, R, KROS, J. M, VAN HEUVEL, I, BROMBERG, J. E, ZONNENBERG, B. A, ZONNENBERG, C. B. L, POSTMA, T. J, GIJTENBEEK, J. M. M

Volltext

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study von Bromberg, Jacoline E C, Issa, Samar, Bakunina, Katerina, Minnema, Monique C, Seute, Tatjana, Durian, Marc, Cull, Gavin, Schouten, Harry C, Stevens, Wendy B C, Zijlstra, Josee M, Baars, Joke W, Nijland, Marcel, Mason, Kylie D, Beeker, Aart, van den Bent, Martin J, Beijert, Max, Gonzales, Michael, de Jong, Daphne, Doorduijn, Jeanette K

Volltext

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure von Poordad, Fred, Pol, Stanislas, Asatryan, Armen, Buti, Maria, Shaw, David, Hézode, Christophe, Felizarta, Franco, Reindollar, Robert W., Gordon, Stuart C., Pianko, Stephen, Fried, Michael W., Bernstein, David E., Gallant, Joel, Lin, Chih‐Wei, Lei, Yang, Ng, Teresa I., Krishnan, Preethi, Kopecky‐Bromberg, Sarah, Kort, Jens, Mensa, Federico J.

Volltext

Ozone effects on blood biomarkers of systemic inflammation, oxidative stress, endothelial function, and thrombosis: The Multicenter Ozone Study in oldEr Subjects (MOSES) von Balmes, John R, Arjomandi, Mehrdad, Bromberg, Philip A, Costantini, Maria G, Dagincourt, Nicholas, Hazucha, Milan J, Hollenbeck-Pringle, Danielle, Rich, David Q, Stark, Paul, Frampton, Mark W

Volltext

Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma von Wilson, Wyndham H, Bromberg, Jacoline E C, Stetler-Stevenson, Maryalice, Steinberg, Seth M, Martin-Martin, Lourdes, Muñiz, Carmen, Sancho, Juan Manuel, Caballero, Maria Dolores, Davidis, Marjan A, Brooimans, Rik A, Sanchez-Gonzalez, Blanca, Salar, Antonio, González-Barca, Eva, Ribera, Jose Maria, Shovlin, Margaret, Filie, Armando, Dunleavy, Kieron, Mehrling, Thomas, Spina, Michele, Orfao, Alberto

Volltext

Health-related quality of life after chemotherapy with or without rituximab in primary central nervous system lymphoma patients: results from a randomised phase III study von van der Meulen, M., Bakunina, K., Nijland, M., Minnema, M.C., Cull, G., Stevens, W.B.C., Baars, J.W., Mason, K.D., Beeker, A., Beijert, M., Taphoorn, M.J.B., van den Bent, M.J., Issa, S., Doorduijn, J.K., Bromberg, J.E.C., Dirven, L.

Volltext